Radicava®/(Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Project: Research project

Project Details

StatusActive
Effective start/end date8/3/208/3/23

Funding

  • Massachusetts General Hospital (Agmt 08/03/20)
  • Mitsubishi Tanabe Pharma America, Inc. (Agmt 08/03/20)